
PHAT Technical Analysis Summary (NASDAQ)
Analyze PHAT on the NASDAQ with RSI, MACD, ADX, Bollinger Bands, support, resistance, momentum, and the latest technical trading signals.
Disclaimer for Technical Analysis Page
The technical indicators and trading signals shown on this page are for informational purposes only and do not constitute financial advice. Stock market investments involve risk, and past performance is not a guarantee of future results. Always conduct your own research or consult a licensed financial advisor before making investment decisions.Read our Full DisclaimerPHAT Technical Analysis Summary (NASDAQ)
Phathom Pharmaceuticals, Inc. (NASDAQ: PHAT) stock currently shows a neutral trend on the NASDAQ, supported by momentum and balanced buying pressure.
Technical conditions suggest Phathom Pharmaceuticals, Inc. on the NASDAQ is awaiting a decisive move. Overall, Phathom Pharmaceuticals, Inc. remains neutral, with indicators showing mixed momentum.
RSI (14): 58.56
Stochastic %K: 54.05
Williams %R: -33.18
Rate of Change (ROC): 3.29
Takeaway:Phathom Pharmaceuticals, Inc. shows steady upward momentum, supported by improving signals.
MACD: 0.17
ADX: 10.63
ATR (14): 0.65
CCI (14): 71.00
Takeaway:Phathom Pharmaceuticals, Inc. shows a neutral trend, with weak conviction and limited volatility.
Takeaway:Phathom Pharmaceuticals, Inc. trades closer to resistance, supported by stronger momentum within bands.
Takeaway:Phathom Pharmaceuticals, Inc. trades above the trend line, showing healthy momentum within the channel.
Overall Takeaway:PHAT shows bullish money flow, with volume and vigor supporting buyers.
Bullish Signals
RSI above 50 → positive momentum from buyers.
MACD above 0 → bullish trend confirmation.
Price trading above middle Bollinger Band → mid-term support intact.
MFI below 80 → room for more buying without overbought risk.
Bearish Signals
No significant bearish signals detected.
Overall Recommendation:Technical indicators for Phathom Pharmaceuticals, Inc. are mixed, suggesting a Hold or wait-and-see approach.